Boston-based life science/clinical screening company PerkinElmer, Inc. has completed its acquisition of drug discovery company Packard BioScience.
Packard BioScience will become part of PerkinElmer’s Life Sciences division.
PBN Branded Content
Beyond Cash Donations: How New Forms of Giving Are Transforming Not-for-Profit Accounting
Evolving Funding Landscape for Not-for-Profits Not-for-profit organizations are being asked to do more with less,…
Learn More
